EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY AND LATE JUVENILE RHEUMATOID ARTHRITIS
<p><em>The article presents results of a study of effectiveness and safety of infliximab — monoclonal antibodies to the tumor necrotizing factor (TNF) in treatment of 100 patients11 months — 17 years old with early and late articular types of juvenile rheumatoid arthritis. The duration o...
Main Authors: | Е.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.O. Lisitsyn |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-01-01
|
Series: | Вопросы современной педиатрии |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/888 |
Similar Items
-
EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY AND LATE JUVENILE RHEUMATOID ARTHRITIS
by: Е.I. Alexeeva, et al.
Published: (2010-05-01) -
TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
by: T.V. Sleptsova, et al.
Published: (2010-01-01) -
TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
by: T.V. Sleptsova, et al.
Published: (2010-09-01) -
Early treatment with infliximab in patients with juvenile idiopathic arthritis
by: Mitenko EV, et al.
Published: (2011-09-01) -
PRACTICE OF INFLIXIMAB TREATMENT OF A PATIENT WITH SEVERE POLIARTICULAR JUVENILE RHEUMATOID ARTHRITIS
by: T.V. Sleptsova, et al.
Published: (2011-09-01)